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One of the vital roles of ascorbic acid (vitamin C) is to act as an antioxidant to protect cellular 
components from free radical damage. Ascorbic acid has been shown to scavenge free radicals 
directly in the aqueous phases of cells and the circulatory system. Ascorbic acid has also been 
proven to protect membrane and other hydrophobic compartments from such damage by 
regenerating the antioxidant form of vitamin E. In addition, reduced coenzyme Q, also a 
resident of hydrophobic compartments, interacts with vitamin E to regenerate its antioxidant 
form. The mechanism of vitamin C antioxidant function, the myriad of pathologies resulting 
from its clinical deficiency, and the many health benefits it provides, are reviewed. 
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"Now I must speak o f  all kinds o f  studies o f  the ant&corbutic factor. It & a 
thankless task because the number o f  research studies is so great that it is 
clearly impossible to review them all," moreover, by failure o f  agreement, 
they present such gaps that it is truly difficult to present a consistent 
thesis. "' 
Mme. L. Randoin, 1923 
INTRODUCTION 
Ascorbic acid (vitamin C) was selected by bio- 
logical systems during evolution to perform a large 
number of vital functions due to its ease of synthesis 
from D-glucose (Nishikimi and Yagi, 1991) and, based 
on its redox potential of +0.080, its efficient donation 
of reducing equivalents to a variety of compounds 
(Davies et al., 1991). Vitamin C was discovered as 
an essential nutritional component in humans by its 
ability to prevent scurvy in individuals deficient in 
vitamin C (Lind, 1753) due to its function in the 
hydroxylation reactions of procollagen (Peterkofsky, 
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1991) and its regulation of collagen synthesis indepen- 
dent of hydroxylation (Houglum et al., 1991). In 
addition to its vital function in connective tissue pro- 
tein post-translational hydroxylation and carnitine 
synthesis (Rebouche, 1991; Ha et al., 1991), vitamin 
C has been shown to facilitate iron absorption (Sie- 
genberg et  al., 1991), regulate cholesterol synthesis 
(Harwood et al., 1986) and elimination (Ginter, 
1978, 1989; Ginter et al., 1981), be involved in or of 
benefit to xenobiotic detoxification (Ginter, 1989; 
Gutierrez, 1988; Brodfuehrer and Zannoni, 1986; 
Matsushita et al., 1993; Nagyova et al., 1994), inhibit 
mutagenesis and carcinogenesis (Kyrtopoulos et al., 
1991; Licht et al., 1988; Fukushima et al., 1990; Mori 
et al., 1988; Pienkowska et al., 1985; Hasegawa et al., 
1990; Hayatsu et al., 1988; Ghaskadbi et al., 1992; 
Anderson and Theron, 1990; Carpenter, 1991; 
Krinsky, 1993; Wise et al., 1993; Liehr et al., 1989), 
0145-479X/94/0800-0349507.00/0 © 1994 Plenum Publishing Corporation 
350 Beyer 
strengthen immune system function (Block et al., 
1991; Dobias et al., 1986; Leibovitz and Siegal, 
1981; Johnston et  al., 1987; Meydani, 1993; Haskell 
and Johnston, 1991; Jacob et  al., 1991; Bendich, 1988, 
1992; Chandra, 1992), have a role in prevention and 
treatment of cancer (Cameron and Pauling, 1976, 
1980; Richards, 1988, 1991; Pavelic et  al., 1989; 
Henson et al., 1991; Block, 1992, 1993; Eichholzer 
et al., 1992; Gey, 1992, 1993; De Loecker et al., 
1993; Huber et  al., 1993; Kaugers et al., 1993), cellu- 
lar differentiation (Franceschi, 1992), cataract and 
inflammatory eye episode prevention (Bensch et al., 
1985; Williams and Paterson, 1986; Garland, 1991; 
Organisciak et  al., 1992; Penn et al., 1992; Taylor, 
1992, 1993; Ames et al., 1993; Bunce, 1993; Eye Dis- 
ease Case-Control Study Group, 1993), regulation of 
aging and inhibition of aging-related pathologies 
(Beyer and Starnes, 1985; Newton et  al., 1985; 
Cutler,. 1986; Sram et 'al., 1990; Garland, 1991; 
Deucher, 1992; Goode et al., 1992; Ames et al., 
1993; Block, 1993; Fernandez-Calle et al., 1993; 
Lopez-Torres et al., 1993; Meydani, 1993), exercise 
injury prevention (Goldfarb, 1993; Jakeman and 
Maxwell, 1993; Peters et al., 1993; Viguie et al., 
1993), cardiovascular disease prevention and hyper- 
tension treatment (Gerster, 1991; Eichhotzer et al., 
1992; Gey, 1992, 1993; Jacques, 1992a, b; Simon, 
1992; Gey et al., 1993; Kaul et al., 1993; Jackques 
et al., 1994), lowering of ischemia-reperfusion injury 
and improvement of organ transplantation success 
(Sakamoto et al., 1992; Doppelfeld and Parnham, 
1992; Lee et al., 1992; Rabl et al., 1993; Rice-Evans 
and Diplock, 1993; Sciamanna and Lee, 1993), treat- 
ment of HIV infection (Harakeh et al., 1990; Baker, 
1991; Harakeh and Jariwalla, 1991; Baruchel and 
Wainberg, 1992), lowering of side-effect toxicity of 
cancer treatment (Fujita et al., 1982; Shimpo et al., 
1991; Rivas-Olmedo et al., 1992), prevention and 
treatment of stroke (Eichholzer et al., 1992), inhibi- 
tion of LDL oxidation (Jailal and Grundy, 1993), 
protection of brain (Makar et al., 1994) and pulmon- 
ary function (Schwartz and Weiss, 1994), and a 
number of other processes. 
Because of the dire consequence and obvious 
association of scurvy resulting from ascorbic acid 
deficiency, it has long been assumed that scurvy is 
the only pathology related to vitamin C deficiency 
and that an intake of vitamin C adequate to prevent 
scurvy is sufficient in all respects. A large number of 
observations have provided strong support for the 
concept that the suggested minimum daily require- 
ment of ascorbic acid (ca. 60mg/day) is insufficient 
and results in subclinical vitamin C deficiency 
associated with a number of clinical entities. The 
pathological consequences of subclinical vitamin C 
deficiency have been detailed in several volumes and 
articles (Stone, 1972; Basu and Schorah, 1982; Clem- 
etson, 1989; Davies et al., 1991; Gaby et al., 1991; 
St~thelin et al., 1991; Eichholzer et al., 1992) and the 
ethical-political aspects of medical use of vitamin C 
have been reviewed (Richards, 1988, 1991). Because of 
the proliferation of publications over the past several 
years regarding the beneficial effects of so-called 
"megadoses" of vitamin C in cancer prevention and 
a large number of other pathologies, the adequacy of 
the RDA of 60mg/day (100mg/day for smokers) 
(Schectman et al., 1991; Schectman, 1993) has been 
questioned and an increased daily consumption 
implied or suggested (Bieri, 1987; Block et al., 1991; 
Block, 1991a, b, 1993a, b; Bates, 1993). As many of 
the pathologies prevented or remedied by vitamin C 
are related to free radical damage to various cellular 
components including membranes (Hayaishi et al., 
1988; Halliwell and Gutteridge, 1989; Beyer, 1990; 
Ernster and Beyer, 1991; Pryor, 1991; Wolff, 1993) 
and, as vitamin C has been shown to act as an efficient 
antioxidant (Bendich et al., 1986; Bieri, 1987; Wefers 
and Sies, 1988; Basaga, 1990; Chow, 1991; Niki, 1991; 
Stocker and Frei, 1991; Byers and Perry, 1992; Meister, 
1992; Sies et al., 1992; Mulholland and Strain, 1993; 
Nordmann, 1993; Rice-Evans and Diplock, 1993; 
Rose and Bode, 1993), it is appropriate that this article 
reviews the recent literature with respect to the anti- 
oxidant function of vitamin C in the protection of 
membranes from free radical damage. 
Vitamin C has been shown to be able to function 
as a chain-breaking antioxidant of lipid peroxidation 
in an in vitro cell-free system (Doba et al., 1985; Niki 
et al., 1985) and to protect various foods from oxi- 
dative deterioration (Cort, 1982; Bendich et al., 1986; 
Frankel, 1989; Niki, 1991). Vitamin C is able to per- 
form as an antioxidant either by reacting directly 
with a number of oxy- or peroxy-radicals in the 
aqueous phase. Since ascorbic acid is a weak, dibasic 
acid which is water soluble at physiological pH, it has 
long been assumed that its antioxidant function is 
confined to the aqueous phase of the cell and circu- 
latory system. However, the demonstration that vita- 
min C may interact with the alpha-tocopheroxyl 
radical, regenerating the antioxidant form of vita- 
min E, alpha-tocopherol (Packer et al., 1979; Niki 
et al., 1982; McCay, 1985), provided evidence that 
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vitamin C also serves indirectly in the protection of 
membrane components susceptible to free radical 
damage. In addition to vitamin E, coenzyme Q in 
the hydroquinone state (CoQH2) has been shown 
to function as an efficient antioxidant in the many 
cellular membranes in which it resides (for reviews 
see Beyer et  al., 1986, 1987; Beyer, 1989, 1990, 
1992, 1994; Beyer and Ernster, 1990; Ernster and 
Beyer, 1991; Ernster and Forsmark-Andr6e, 1993). 
This review, then, will report some of the relatively 
recent findings demonstrating the antioxidant role of 
vitamin C in the protection of membranes, and other 
hydrophobic compartments, from oxidative free 
radical damage. 
ANTIOXIDANT CHEMISTRY AND 
MECHANISMS 
Ascorbic acid (AH2) has a dissociation constant 
in water of 7.94 x 10 s (pKa = 4.10) (Handbook, 
1992-93), resulting in the dominant form at pH7 
being the ascorbate anion (AH-). Dehydroascorbic 
acid (A) can also be formed via a two-step reversible 
oxidation process involving the formation of the inter- 
mediate ascorbyl radical (A-) (Laroff et  al., 1972). 
The interconversions of these three forms of vitamin 
C are shown in Fig. 1. The dehydroascorbate com- 
ponent may exist in several states, the hydrated 
hemiketal being the preferred state under aqueous con- 
ditions (Tolbert and Ward, 1982). It is important to 
note that delocalization of the unpaired electron in 
the ascorbyl radical (A -°) renders it rather unreactive. 
Its fate is to disproportionate according to the sequence 
2A -° + H + --4 AH-  + A (1) 
or it may react with other free radicals and in so doing 
it terminates the propagation of free radical reactions 
in which it may be involved (Bielski, 1982). 
Ascorbic acid is able to react with the superoxide 
radical as shown in reaction (2): 
02 -° -}-AH- --+ HO 2- + A-" (2) 
HO H HO H HO H 
~. : 0 0 -H* ~ u , ~  ~ 0 T D O  \ 
~e~ ~ [ ..~0 • (,,,0~00 0 6 / ~  ,e ' ' - c - -  \ 0 ~ 0  ~ + e- 
O- OH *H* 
L-Ascorbote (pK=/..2) Ascor byl Dehydro-L- ascor bic acid 
Radical 
Fig. 1. Molecular interconversion of vitamin C. 
and is also able to scavenge the hydroxyl (or per- 
hydroxyl) radical: 
HO 2" q- AH-  -+ H202 -k A-"  (3) 
Formation of the superoxide and hydroperoxyl 
radicals are considered the most common under 
physiological conditions (Fridovich, 1976) and their 
reactions with ascorbate have been studied with flash 
photolysis and pulse radiolysis (Bielski, 1982; Cabelli 
and Bielski, 1983; Nadezhdin and Dunford, 1979). In 
addition, ascorbate is able to react efficiently and 
directly with the following radical species with k 
values between 2 x 10 -6 and 2 x 10 .8 M -1 s-l: 
C13COO', C12CHOO', C1CH2OO', "OOCC12CO2-, 
"OOCHC1CO2-, CH3OO', and (CH3)2C(OH) • 
CH2OO" (Niki, 1991). Ascorbate has also been 
shown to be an effective scavenger of singlet oxygen 
(Bodannes and Chan, 1979) as well as the highly 
damaging hydroxyl radical (OH') (Rose, 1990). 
In the presence of transition metals, and at high 
concentrations of ascorbate, hydroperoxyl and super- 
oxide radicals may be formed in vitro (Halliwell and 
Gutteridge, 1989; Cheeseman et  al., 1984). The auto- 
oxidation of ascorbate proceeds with the formation of 
an intermediate superoxide anion: 
AH-  + 02 --+ A-" + 02-" -1- H + (4) 
a process which is inhibited in the presence of the 
enzyme superoxide dismutase (Puget and Michael- 
son, 1974; Scarpa et al., 1983). 
Although the ability of ascorbic acid, at high 
concentrations, to form free radicals and initiate the 
process of lipid peroxidation has been demonstrated 
in vitro (Girotti, 1985), leading to rumors that high 
intakes of vitamin C results in damage to the recipi- 
ent, there is little objective evidence supporting 
significant prooxidant activity of ascorbic acid in 
vivo (Bendich et  al., 1986). 
ANTIOXIDANT HYDROPHOBIC PHASE 
MEMBRANE PROTECTION 
A number of hydrophobic phase and membrane 
components including polyunsaturated fatty acids 
and esters, lipoproteins, and phospholipids are 
oxidized by free radicals in a three-stage chain oxida- 
tion process of lipid peroxidation. This process, and 
the antioxidant effects of ascorbic acid, has been stud- 
ied in vitro using azo initiators (A-N=N-A) ,  such 
as 2,2'-azobis(2-amidinopropane)dihydrochloride, 
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which are able to generate free radicals (Yamamoto 
et  al., 1984; Barclay et  al., 1984). The reactions of the 
three stages of azo dye-initiated lipid peroxidation are 
shown in reaction (5)-(10), where A - N = N = A  is the 
azo initiator, LH is a lipid, L" a lipid radical, and LO2" 
a lipid peroxyl radical. 
Initiation: 
A - N = N - A  --+ A" + N 2 + "A (5) 
A" + O 2 ~ AO2 ° (6) 
AO2 ° + LH + O 2 ~ AOOH + LO2 ° (7) 
Propagation: 
L O  2" + LH ---+ LOOH + L" (8) 
L" + 0 2 ~ LO2 ° (9) 
Termination: 
2LO2" ~ Inert products (10) 
Chain-breaking antioxidants, including ascorbic 
acid, inhibit the peroxidation process by scavenging 
AO2" or LO2" radicals, thereby inhibiting the initi- 
ation stage. As Niki et  al. (1984) have demonstrated, 
the length of the induction period of the initiation 
stage of azo initiator-induced oxidation of methyl 
linoleate in organic solvent is directly proportional 
to ascorbic acid concentration. Ascorbic acid has 
also been shown to inhibit the oxidation of aqueous 
phase-dispersed phosphatidylcholine liposomes and 
methyl linoleate micelles under conditions of free 
radical generation in the aqueous phase (Yamamoto 
et  al., 1984; Niki et  al., 1985; Doba et  al., 1985). 
Ascorbic acid has also been shown to prevent free 
radical damage to membranes of erythrocytes in 
aqueous suspension via oxidation of membrane pro- 
teins and lipids resulting in hemolysis (Yamamoto 
et  al., 1986; Miki et  al., 1987; Niki, 1987). On  the 
basis of such observations, it has been concluded 
that ascorbic acid scavenges oxygen radicals formed 
in the aqueous phase before the radicals attack 
erythrocyte membranes, and thus it protects mem- 
branes from oxidative damage (Niki, 1991). 
Biological systems possess a large variety and 
concentration of radical-trapping antioxidants 
(Halliwell and Gutteridge, 1989), some of which are 
primary (major or only function) and some of which 
are secondary or incidental (Beyer, 1994). Measure- 
ment of total radical-trapping antioxidant potential 
(TRAP) in blood plasma indicates that vitamin C, 
vitamin E, urate, protein (Wayner et al., 1985, 
1987), and coenzyme Q (Beyer, 1992) are the major 
functional antioxidants. Niki et  al. (1988) have 
demonstrated that, during free radical generation in 
the aqueous phase of whole blood suspensions, a 
number of antioxidants in both the plasma and the 
erythrocytes interact with the radicals and decrease 
oxidative damage. The primary antioxidant, which is 
the most efficient and is consumed prior to utilization 
of the other antioxidants, is ascorbic acid, followed by 
bilirubin, uric acid, coenzyme Q, and vitamin E 
in plasma. After most of the plasma antioxidant 
capacity is depleted, erythrocyte membrane vitamin 
E and -SH groups commence function. Niki (1991) 
has offered the logical explanation that vitamin C is 
the "primary and the most important defence against 
the radicals in the aqueous phase." 
One question concerning the antioxidant func- 
tion of vitamin C which must be addressed is the 
relevance of mechanistic and in vitro studies to the 
role of vitamin C in vivo. Using a vitamin C-deficient 
rat model, Kunert and Tappel (1983) have demon- 
strated an increase in whole-body lipid peroxidation 
while Kato et  al. (1981) have reported inhibition by 
ascorbic acid of lipid peroxidation in rat liver. 
Although vitamin C has been shown conclusively 
to be an efficient antioxidant in the aqueous phase, its 
lack of solubility in the membrane hydrophobic phase 
restricts its ability to inactivate free radicals formed 
within membranes or block their damaging effects 
(Niki et  al., 1985; Doba et  al., 1985). 
ROLE OF VITAMIN C IN ANTIOXIDANT 
PROTECTION OF MEMBRANES 
As mentioned above, although ascorbic acid is 
able to protect membranes from free radicals gener- 
ated in the aqueous phase, it is not an efficient scaven- 
ger of free radicals generated within the hydrophobic 
membrane phase. As first suggested by Tappel (1962, 
1968), aerobic organisms have selected a mechanism 
to protect membranes from free radical damage utiliz- 
ing a chemical interaction between ascorbic acid in the 
aqueous phase and regeneration of alpha-tocopherol 
in the membrane hydrophobic phase. The literature 
regarding the role of ascorbic acid in the generation of 
the active antioxidant form of vitamin E, alpha- 
tocopherol, up to 1988 has been reviewed (Niki, 
1991). Recent information relevant to the role of anti- 
oxidants functional in the membrane phase (vitamin E 
and coenzyme Q) and the regeneration of their active 
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antioxidant forms will now be addressed. In general, 
recent literature on the interaction between vitamin C 
and vitamin E has provided strong support for the 
nonenzymatic regeneration of alpha-tocopherol 
(TCOH) from the alpha-tocopheroxyl radical 
(TCO'), formed when alpha-tocopherol scavenges a 
peroxyl radical (ROO'), by ascorbate (AH-) as 
shown in reactions (11) and (12): 
ROO" + TCOH - ,  ROOH + TCO" (11) 
TCO" + AH- -+ TCOH + A-" (12) 
Ascorbate is regenerated either by GSH-dependent 
dehydroascorbate reductase (Halliwell and Gutter- 
idge, 1989) or nonenzymatically by dihydrolipoic 
acid (Constantinescu et  al., 1993). Because free radi- 
cals generated in biological systems at physiological 
pH, and their reduced forms, are uncharged, it has 
been hypothesized (Njus and Kelly, 1991) that both 
vitamins C and E donate single hydrogen atoms in 
vivo instead of separate electron transfer and proton 
equilibrium steps. The dependence of ascorbate and 
glutathione upon vitamin E in protection against 
microsomal lipid peroxidation has been reported by 
Wefers and Sies (1988a), and the same authors have 
reviewed the roles of vitamins E and C, beta-carotene, 
and other carotenoids in antioxidant defense (Wefers 
and Sies, 1988b; Sies et  al., 1992). A significant 
contribution to the understanding of the functional 
significance of the interactive antioxidant roles of 
vitamins C and E has been provided by the demon- 
stration of this process in vivo utilizing a mutant rat 
strain unable to synthesize ascorbic acid (Igarashi 
et al., 1991). The antilipoperoxidant activities of 
alpha-tocopherol and ascorbic acid, protecting 
erythrocyte membranes, have been shown to be 
potentiated by rutin (N~gre-Salvayre et al., 1991), a 
water-soluble flavenoid, secondary antioxidant 
(Beyer, 1994). 
The beneficial effect of an increase in the total 
radical-trapping antioxidant potential (TRAP) of 
plasma of humans, stimulated by oral supplementa- 
tion with large doses of vitamins C and E, has been 
reported (Mulholland and Strain, 1993). Using an 
ESR steady-state method, Roginsky and Stegmann 
(1993) have studied the kinetics of the reaction 
between ascorbate and the phenoxyl radical from 
alpha-tocopherol. In a recent publication on "the 
pecking order of free radicals and antioxidants," 
Buettner (1993) has reviewed the thermodynamics 
of free radical reactions of interest to health, the 
fundamental thermodynamics and kinetic properties 
associated with chain-breaking antioxidants, and the 
"interfacial" nature of the reaction between the 
tocopheroxyl free radical and ascorbate. In a review 
appropriately entitled "Partners in Defense, Vitamin 
E and Vitamin C," Chan (1993) has reviewed the 
concept of nonenzymic regeneration of vitamin E by 
vitamin C and the enzymatic regeneration of 
hydrophobic-phase vitamin E by glutathione. Con- 
tributions to understanding the interactive roles of 
vitamins C and E in the prevention of free radical 
oxidation of plasma LDL, an essential event in 
cholesterol plaque formation, have been published 
recently (Frei, 1991; Mackness et al., 1993) and 
reviewed (Jackson et al., 1993). 
In addition to vitamin C, reduced coenzyme Q 
(CoQH2) has been shown to protect the many cellu- 
lar membranes and plasma lipoproteins in which it 
resides from free radical damage (see Beyer, 1992, 
1994 for recent reviews). In addition to direct inter- 
action of CoQH2 with lipid peroxyl radicals (Beyer, 
1988; Beyer et  al., 1987), CoQH2 has been shown to 
be an efficient regenerator of alpha-tocopherol from 
the tocopheroxyl radical (Frei et al., 1990; Mukai 
et al., 1990, 1992; Packer et al., 1991; Ernster et al., 
1992; Freisleben and Packer, 1993). The possible 
sequence of events depicting the interaction of 
CoQH 2 with the superoxide radical (02- ')  and the 
perferryl radical (Fe3+-O2 - ' )  (cf. Beyer and Ernster, 
1990; Beyer, 1992) are shown in reactions (13) and 
(14): 
CoQH2 + O2-" --" CoQ-" + H202 (13) 
CoQH2 + Fe3+-O2 -" --+ 
CoQ-" + Fe 3+ + H202 (14) 
The H202 generated in reactions (13) and (14) would 
be removed by catalase, peroxidase, or GSH- 
peroxidase (Beyer, 1992). The quenching of carbon- 
centered lipid radicals CL') and/or lipid peroxyt 
radicals (LOO') by CoQH2 has also received consid- 
eration (Beyer and Ernster, 1990; Forsmark et al., 
1991) and is depicted in reactions (15) and (16): 
CoQH2 + L" --* CoQ-" + LH + H + (15) 
CoQH 2 + LOO" --+ CoQ-" + LOOH + H + (16) 
As mentioned above, reduced coenzyme Q is able to 
regenerate the active form of vitamin E from the 
alpha-tocopheroxyl radical (TCO') according to 
354 Beyer 
reaction (17): 
CoQH 2 + TCO" --- CoQ-" + TCOH + H + (17) 
Another possible mechanism accounting for the anti- 
oxidant activity of CoQH2 is derived from observa- 
tions of Cadenas et al. (1988) who have observed the 
interaction of superoxide dismutase (SOD) with 
hydroquinones and, in conjunction with the two- 
electron quinone reductase DT-diaphorase (Ernster 
et al., 1987), inhibits autooxidation of hydro- 
quinones. Cadenas et al. (1988) have proposed a 
new function for SOD, a superoxide:semiquinone 
oxidoreductase activity, in which SOD-Cu 2+ is 
reduced by the superoxide radical: 
SOD-Cu 2+ + O -° -+ SOD-Cu + + 02 (18) 
followed by oxidation of SOD-Cu + by a semiquinone 
intermediate: 
SOD_Cu + + Q-. ~ SOD_Cu2+ + Q2- (19) 
If, in fact, DT-diaphorase were able to interact with 
coenzyme Q to form CoQH2, indirect evidence for 
which has been presented (Beyer, 1994), the sum of 
reactions (18) and (19) is shown in reaction (20): 
0 2  - °  Jr- CoQ-" -- ,  0 2  -1- CoQ 2- (or CoQH2) (20) 
The reaction between DT-diaphorase and coenzyme 
Q Would dismutate the CoQ semiquinone and thus 
prevent the transfer of the unpaired electron to 
oxygen and formation of the superoxide radical. 
Although it may be argued that, based upon the 
high degree of hydrophilicity of ascorbic acid and 
hydrophobicity of alpha-tocopherol, requiring resi- 
dence in two distinct cellular compartments, the 
chemical interaction of the two molecules is unlikely 
in vivo, a number of studies clearly indicate just such 
synergistic interaction in liposomal and membrane 
systems (Niki et al., 1985; Doba et al., 1985; Chan, 
1993; Buettner, 1993; Roginsky and Stegmann, 1993; 
Sies et al., 1992; N~gre-Salvayre et  al., 1991). Recent 
studies have also demonstrated synergism between 
vitamins C and E in vivo (Anderson and Theron, 
1990; Igarashi et al., 1991; Mulholland and Strain, 
1993). 
CONCLUSIONS 
Very convincing evidence exists providing strong 
support for an antioxidant role for ascorbic acid, 
protecting not only the aqueous compartments of 
the cell, extracellular matrix, and circulatory system 
in which it resides but, in addition, hydrophobic 
phases such as circulatory system lipoproteins and 
membrane systems in general. Ascorbic acid may per- 
form its antioxidant function either by quenching 
various free radical species directly or by reducing 
membrane-bound oxidized vitamin E at the mem- 
brane surface. The ability of reduced coenzyme Q, 
also a membrane-bound component, to also regener- 
ate the antioxidant form of vitamin E has also been 
demonstrated. Further experiments should be 
designed to investigate in detail the interaction of 
vitamins C and E, and coenzyme Q, all powerful 
antioxidants, in the vital protection of membrane com- 
ponents against injury from damaging free radicals. 
NOTE ADDED IN PROOF 
Subsequent to submission of the manuscript, a 
number of articles relevant to issues treated above 
have been published. In addition to the impressive 
number of functions listed in the Introduction 
section, vitamin C has been reported to be of benefit 
to patients with macular degeneration (Seddon and 
Hunnekens, 1994) and HTLV-I-associated myelo- 
pathy (Kataoka et al., 1993) and may exert a protective 
effect against the development of gastric cancer in 
humans (Dyke et al., 1994). In addition, vitamin C 
has been shown to protect cells from free radical da- 
maging effects of gamma-radiation in embryos 
CYoshimura et al., 1993) and testes (Nara et al., 
1994) and to function as a vital antioxidant in the 
brain (Reiber et al., 1994). Ascorbic acid treatment 
has also been shown to protect against the free 
radical-associated toxic effects of cadmium (Shiraishi 
et al., 1993), trimethyltin (Bannon et al., 1993) and 
endotoxin-induced lung injury (Dwengen et al., 
1994). Recent evidence also indicates that vitamin C 
decreases endogenous lipid peroxidation (Chakra- 
borty et al., 1994, Garg and Mahajan, 1993; Barja et 
al., 1994), protein oxidative damage (Barja et al., 
1994), affects longevity (Garg and Mahajam, 1993; 
Yu, 1994), inhibits skin tumor promotion (Battalora 
et al., 1993), protects the liver from oxidative damage 
(Chen and Tappel, 1994) and reduces erythrocyte 
membrane nitroxide radicals (Zhang and Fung, 
1994). Synergism between vitamins C and E in mem- 
brane protection has been confirmed (Lambelet et al., 
1994) and reviewed (Reed, 1993). The protective role 
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of coenzyme Ql0 in low density lipiprotein oxidizability 
by copper has also been demonstrated (Kontash et al., 
1994). Current controversies regarding use of vitamin 
supplements have been reviewed (Reynolds, 1994) and 
the conclusion reached that high-dose nutritional 
vitamin supplementation provides major benefits with 
respect to prevention of cancer, cardiovascular disease, 
carpal tunnel syndrome, and neural tube defects, "to 
name a few." In addition, review articles, regarding 
nutrient antioxidants and cellular defense mechanisms 
against damage from free radicals have appeared (Yu, 
1994; Bonorden and Pariza, 1994). 
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